Evidence map›Paper›PMID 25391659›Full record

ArticleCellular and molecular life sciences : CMLS2015

MEK1 transduces the prion protein N2 fragment antioxidant effects.

C L Haigh, A R McGlade, S J Collins

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Prion Protein: The Molecule of Many Forms and Faces.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Prions and prion diseases: Insights from the eye.Experimental eye research · 2020
    Review
  10. Review
  11. Article
  12. Prion Protein in Glioblastoma Multiforme.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Physiological Functions of the Cellular Prion Protein.Frontiers in molecular biosciences · 2017
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C L HaighDepartment of Pathology, Melbourne Brain Centre, The University of Melbourne, Parkville, Melbourne, 3010, Australia, chaigh@unimelb.edu.au.
A R McGlade
S J Collins

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prion protein (PrP(C)) when mis-folded is causally linked with a group of fatal neurodegenerative diseases called transmissible spongiform encephalopathies or prion diseases. PrP(C) normal function is still incompletely defined with such investigations complicated by PrP(C) post-translational modifications, such as internal cleavage, which feasibly could change, activate, or deactivate the function of this protein. Oxidative stress induces β-cleavage and the N-terminal product of this cleavage event, N2, demonstrates a cellular protective response against oxidative stress. The mechanisms by which N2 mediates cellular antioxidant protection were investigated within an in vitro cell model. N2 protection was regulated by copper binding to the octarepeat domain, directing the route of internalisation, which stimulated MEK1 signalling. Precise membrane interactions of N2, determined by copper saturation, and involving both the copper-co-ordinating octarepeat region and the structure conferred upon the N-terminal polybasic region by the proline motif, were essential for the correct engagement of this pathway. The phenomenon of PrP(C) post-translational modification, such as cleavage and copper co-ordination, as a molecular "switch" for activation or deactivation of certain functions provides new insight into the apparent multi-functionality of PrP(C).

Indexed as

Amino Acid SequenceAnimalsAntioxidantsCell LineHumansMAP Kinase Kinase 1MiceMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Oxidative StressPeptidesPhosphatidylinositol 3-KinasesPrionsPrPC ProteinsReactive Oxygen SpeciesReceptors, LamininAntioxidantsMAP Kinase Kinase 1Mitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3PeptidesPhosphatidylinositol 3-KinasesPrionsPrPC ProteinsReactive Oxygen SpeciesReceptors, Laminin

Identifiers

PMID25391659
PMCPMC11114014

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.